The clinical utility of CRP-guided triage is also dependent on TB prevalence: it is likely to be useful across a wider NWT range in settings with lower TB prevalence, while confirmatory testing for all is likely to be preferable when the TB prevalence is high. This evidence concerns the gene CRP and tuberculosis.